ARDX: Ardelyx, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,582.26
Enterprise Value ($M) 1,630.80
Book Value ($M) 166.82
Book Value / Share 0.72
Price / Book 9.49
NCAV ($M) 115.35
NCAV / Share 0.50
Price / NCAV 13.72

Profitability (mra)
Return on Invested Capital (ROIC) -0.27
Return on Assets (ROA) -0.30
Return on Equity (ROE) -0.53

Liquidity (mrq)
Quick Ratio 4.64
Current Ratio 4.88

Balance Sheet (mrq) ($M)
Current Assets 246.11
Assets 297.58
Liabilities 130.76
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 124.46
Operating Income -63.28
Net Income -66.07
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -89.72
Cash from Investing -131.25
Cash from Financing 146.29

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Janus Henderson Group Plc 10.60 24.70
02-13 13G Vanguard Group Inc 5.61
01-31 13G/A Millennium Management Llc 0.00 -99.94
01-30 13G/A State Street Corp 7.37 -23.78
01-26 13G BlackRock Inc. 7.20 198.03

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-10-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-16 558,179 3,017,157 18.50
2024-04-15 913,791 1,611,153 56.72
2024-04-12 738,081 1,366,973 53.99
2024-04-11 938,893 1,627,033 57.71

(click for more detail)

Similar Companies
APLT – Applied Therapeutics, Inc. AQST – Aquestive Therapeutics, Inc.
ARCT – Arcturus Therapeutics Holdings Inc. ATAI – Atai Life Sciences N.V.
ATXS – Astria Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: Ardelyx